Th9 cells promote antitumor immune responses in vivo
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Th9 cells are a subset of CD4+ Th cells that produce the pleiotropic cytokine IL-9. IL-9/Th9 can function as both positive and negative regulators of immune response, but the role of IL-9/Th9 in tumor immunity is unknown. We examined the role of IL-9/Th9 in a model of pulmonary melanoma in mice. Lack of IL-9 enhanced tumor growth, while tumor-specific Th9 cell treatment promoted stronger antitumor responses in both prophylactic and therapeutic models. Th9 cells also elicited strong host antitumor CD8+ CTL responses by promoting Ccl20/Ccr6-dependent recruitment of DCs to the tumor tissues. Subsequent tumor antigen delivery to the draining LN resulted in CD8+ T cell priming. In agreement with this model, Ccr6 deficiency abrogated the Th9 cell-mediated antitumor response. Our data suggest a distinct role for tumor-specific Th9 cells in provoking CD8+ CTL-mediated antitumor immunity and indicate that Th9 cell-based cancer immunotherapy may be a promising therapeutic approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“IL-9 has been shown to favour CD8 T-cell activation in a model of pulmonary melanoma in mice36.”
From Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of TH9 cells (2017) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“This observation is in contrast to previous findings demonstrating a role of Th9 cells in controlling anti-tumour immune responses in solid tumours such as melanomas.26,27”
From PU.1-driven Th9 Cells Promote Colorectal Cancer in Experimental Colitis Models Through Il-6 Effects in Intestinal Epithelial Cells (2022) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617
Differential Antigen Processing by Dendritic Cell Subsets in Vivo
Dudziak, D., Kamphorst, A. O., Heidkamp, G. F., Buchholz, V. R., Trumpfheller, C., Yamazaki, S., Cheong, C., Liu, K., Lee, H.-W., Park, C. G., et al. (2007) · Science · doi:10.1126/science.1136080 · Cited by 1,455
The Central Role of CD4+ T Cells in the Antitumor Immune Response
Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., & Levitsky, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2357 · Cited by 1,345
Veldhoen, M., Uyttenhove, C., van Snick, J., Helmby, H., Westendorf, A., Buer, J., Martin, B., Wilhelm, C., & Stockinger, B. (2008) · Nature Immunology · doi:10.1038/ni.1659 · Cited by 1,213
Dardalhon, V., Awasthi, A., Kwon, H., Galileos, G., Gao, W., Sobel, R. A., Mitsdoerffer, M., Strom, T. B., Elyaman, W., Ho, I.-C., et al. (2008) · Nature Immunology · doi:10.1038/ni.1677 · Cited by 1,122
Maldonado-López, R., De Smedt, T., Michel, P., Godfroid, J., Pajak, B., Heirman, C., Thielemans, K., Leo, O., Urbain, J., & Moser, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.587 · Cited by 984
Tumor-specific Th17-polarized cells eradicate large established melanoma
Muranski, P., Boni, A., Antony, P. A., Cassard, L., Irvine, K. R., Kaiser, A., Paulos, C. M., Palmer, D. C., Touloukian, C. E., Ptak, K., et al. (2008) · Blood · doi:10.1182/blood-2007-11-120998 · Cited by 845
IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
Wang, L., Yi, T., Kortylewski, M., Pardoll, D. M., Zeng, D., & Yu, H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090207 · Cited by 842
Self-citationT Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
Martin-Orozco, N., Muranski, P., Chung, Y., Yang, X. O., Yamazaki, T., Lu, S., Hwu, P., Restifo, N. P., Overwijk, W. W., & Dong, C. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.014 · Cited by 800
Helping the CD8+ T-cell response
Bevan, M. J. (2004) · Nature Reviews Immunology · doi:10.1038/nri1413 · Cited by 797
Cited by
Items 301–382 of 382
Saeki, M., Kaminuma, O., & Hiroi, T. (2020) · Folia Pharmacologica Japonica · doi:10.1254/fpj.20054 · Cited by 2
Signaling of Tumor-Induced Immunosuppression of Dendritic Cells
Lu, Y., Yang, J., & Yi, Q. (2013) · Springer eBooks · doi:10.1007/978-94-007-6217-6_14 · Cited by 1
Self-citationAdaptive immunity and metabolism
Verbist, K., Sharma, P., Beere, H. M., & Green, D. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-15447-8.00008-8 · Cited by 1
Elucidating the role of regulatory T cells in colorectal cancer progression
Besneux, M. (2015) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 2
γ c Family Cytokines: Role in Immune Cell Development and Function
Wan, E. C. K., & Leonard, W. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.10010-4 · Cited by 1
γc-Family Cytokines in Health and Disease
Leonard, W. J., Pandit, H., Spolski, R. J., & Lin, J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00096-x · Cited by 1
Quality of CTL Therapies: A Changing Landscape
Thyagarajan, K., Chatterjee, S., Kesarwani, P., Nishimura, M. I., & Mehrotra, S. (2015) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-17807-3_14
T H 9 Cells in Immunity and Disease
Chang, H., & Kaplan, M. H. (2015) · Wiley eBooks · doi:10.1002/9780470015902.a0026234
A Subset Apart? Th9 cell regulation and current limitations to study
Zheng, Z., & Kang, J. (2015) · Journal of nature and science
Cancer Immunotherapies: Where We Stand? Where We Will Go?
Lu, Y. (2014) · MOJ Immunology · doi:10.15406/moji.2014.01.00002
Self-citationD'Almeida, S. M. (2015) · theses.fr (ABES) · doi:10.70675/92b9d3a7zb03dz4e4ezae4cz12285759bf0b
The Differentiation and Function of Th2 and Th9 Cells
Gros, G. S. L., & Kyle, R. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.08003-6
Th9 Cells as Targets for Immunotherapy
Awe, O., & Kaplan, M. H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801577-3.00007-1
Information-dense analysis for information-dense understanding
Ivica, N. A., Kaur, M., Hu, G., & Chen, J. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.11.21
Sun, H., Sun, C., & Tian, Z. (2016) · Springer eBooks · doi:10.1007/978-94-024-0902-4_3 · Cited by 1
Caractérisation et influence des lymphocytes T CD4 anti-télomérase dans les cancers
Dosset, M. (2012) · theses.fr (ABES) · doi:10.70675/f11f022bzcc58z45a9z95d7zbc676c861177 · Cited by 1
Humblin, É., Ghiringhelli, F., & Végran, F. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6877-0_13
T helper Regulation and Anti-Cytokine Therapy in Asthma
Zheng, Z. (2015) · International Journal of Allergy Medications · doi:10.23937/2572-3308.1510003
Th9 Cells: From the Bench to the Bedside and Back Again
Ulrich, B. J., Hufford, M. M., & Kaplan, M. H. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch15
Immunomodulation and Vaccination with RHDV VLP
Donaldson, B. (2017) · Otago University Research Archive (University of Otago) · Cited by 1
The Secrets of T Cell Polarization
Vargas, T. R., & Apétoh, L. (2017) · Springer eBooks · doi:10.1007/978-3-319-62431-0_5 · Cited by 1
The Janus-Faced Role of Cell-Mediated Immune Responses in Pancreatic Cancer
Niccolai, E., Taddei, A., Ricci, F., Ringressi, M. N., & Amedei, A. (2017) · EMJ Oncology · doi:10.33590/emjoncol/10313163
Polarização de linfócitos: Relevância fisiopatológica de Th9 e Th17
Degasperi, G. R., Camargo, R. C., Ribeiro, T. C. S., Rodrigues, T. C. R., & Barille, G. (2018) · Saúde (Santa Maria) · doi:10.5902/2236583432689 · Cited by 2
Étude de la régulation transcriptionnelle des lymphocytes Th9
Humblin, É. (2017) · theses.fr (ABES) · doi:10.70675/32817b37zf0dbz487ez9d03zebd725df9ce2
Rôle pronostique des infiltrats lymphocytaires T CD4 dans les cancers du sein
Thibaudin, M. (2017) · theses.fr (ABES) · doi:10.70675/ac27a852zb999z41d6z995dze3552753ae27
Xie, M. M. (2019) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1758
Identifying Molecular Determinants of Immune Rejection in Pancreatic Cancer
Ajina, R. (2020) · DigitalGeorgetown (Georgetown University Library)
In-Vitro Inhibition of P38 Abrogates GITR-Induced Proliferation of Murine iTregs
Davis, A. J. (2020) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Vieira, R. D. S. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2021.tde-14012022-162330
Microbiota y su relación en el cáncer
Ordóñez, G. D. B., Anguisaca, C. F. O., & Carpio, C. A. M. (2021) · Revista del Centro de Investigación de la Universidad la Salle · doi:10.26457/recein.v14i56.2853
Alvarez-Buylla, E. R., Martínez‐García, J. C., Dávila-Velderrain, J., Domínguez‐Hüttinger, E., & Martínez-Sánchez, M. E. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-89354-9_3
Mimicking Mechanical Features of the Tumor Microenvironment
Mierke, C. T. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839166013-00060
Pan, H., Tian, Y., Pei, S., Yang, W., Zhang, Y., Gu, Z., Zhu, H., Zou, N., Zhang, J., Jiang, L., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4596465
Gouyou, B. (2020) · theses.fr (ABES) · doi:10.70675/9acb8a91z1b56z4ef6za179zbe41856d4de9
The role of cellular persistence in CAR T cell therapy
Menkhoff, V. D., Bernhard, S., Michaelides, S., Stock, S., & Kobold, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00029-1
The Role of NAD+-Dependent Signal Mechanisms in Cancer Development and Treatment
Lu, T., Qin, Z., & Wu, J. (2025) · Springer eBooks · doi:10.1007/978-981-97-9877-3_33 · Cited by 1
A little less reading, a little more type 9 action
Jackson, K. G., & Kaplan, M. H. (2025) · Nature Immunology · doi:10.1038/s41590-025-02253-0
Kumar, S., Chan, C. J., Coussens, L. M., Whiteside, S. K., & Roychoudhuri, R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00164-2
Immunotherapy for Cutaneous Melanoma
Soleymanitabar, A., Keshavarz‐Fathi, M., Hargadon, K. M., & Rezaei, N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00769-8_237
Pan, H., Tian, Y., Pei, S., Yang, W., Zhang, Y., Gu, Z., Zhu, H., Zou, N., Zhang, J., Jiang, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25852984
Stearoyl-CoA desaturase-1 controls the differentiation and antitumoral function of Th9 lymphocytes
Groetz, E., Perrey, S., Garcia, A. B., Dumont, A., Pichon, L., Kieu, C. T. L. V., Pierre, L., Thomas, C., Flavell, R. A., Limagne, E., et al. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-013102
Induction of IL‐9‐producing CD8 + T cells by ascochlorin derivatives
Imano, N., Nishida, M., Tokumasu, M., Zhao, W., Yamashita, N., & Udono, H. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70316
Bruchard, M. (2013) · theses.fr (ABES) · doi:10.70675/7c90008ezea1ez453cza8f2zf6aca7d2beb5
Berger, H. (2015) · theses.fr (ABES) · doi:10.70675/33cee056zccc3z4978z8945z12c4fd4adfab · Cited by 1
Recherche de biomarqueurs pronostiques dans le cancer de la vessie dans la population Tunisienne
Bahria-Sediki, I. B. (2016) · theses.fr (ABES) · doi:10.70675/09c408d9z562fz4b26z81d8z7c9ce2d9d9f9
Impact des inhibiteurs de la voie mTOR sur la réponse immunitaire T anti-tumorale
Beziaud, L. (2015) · theses.fr (ABES) · doi:10.70675/02936eacz6998z4fd1zb56cz2535d854411e
Parrot, T. (2016) · theses.fr (ABES) · doi:10.70675/39ff19cfz09e9z4622zb993z8b20e55db170
Simonneau, M. (2018) · theses.fr (ABES) · doi:10.70675/34bc0b41z17a7z49e0zb6c5zd874a4c8cbeb · Cited by 1
Chraa, D. (2019) · theses.fr (ABES) · doi:10.70675/8ad0de1ezeb55z4983z9084z94cc8799b353
Schmitt, P. (2019) · theses.fr (ABES) · doi:10.70675/910c14fdzc720z4a3fza364z6abf25ce9c20
Benoit-Lizon, I. (2021) · theses.fr (ABES) · doi:10.70675/2b159c6dz31eez488ez8948z2fc5261a35dc
Caractérisation transcriptomique des cellules lymphoïdes innées
Crinier, A. (2020) · theses.fr (ABES) · doi:10.70675/850e38aazc227z4187z9c41z07c47cac00d9
Systematic Study of OX40 Ligand Context-Dependent Function on Human T Helper Cell Polarization
Karpf, L. (2020) · theses.fr (ABES) · doi:10.70675/b19ae5a1z0ff8z4de6zb2bczca89c6e7a7da
Vermeulen, O. (2021) · theses.fr (ABES) · doi:10.70675/277aa48cz7ec5z4c99z9fe9z34e8ea73f6b5
Optimisation de traitements immunothérapeutiques dans le cancer
Chavanton, A. (2024) · theses.fr (ABES) · doi:10.70675/7ea8dbe3z70b3z448fz90cez6a61ae774c59
Peroceschi, R. (2024) · theses.fr (ABES) · doi:10.70675/1253a351z345ez4a59za033z3f19256baba1
Adimi, Y. (2025) · theses.fr (ABES) · doi:10.70675/f93fdc0az5f36z4bbdza55az8e312d9ecc0b
Song, Y., Li, R., Han, L., Liu, W., & Bu, X. (2026) · Gastrointestinal Tumors · doi:10.48130/git-0026-0007
Zhu, Q., Chen, Y., Gao, J., Tang, P., Ma, Z., Li, X., Jiang, H., Huang, Z., Zang, Y., Zhao, X., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.29.721605
Feng, L., Cheng, J., Wang, Q. Y., Wu, Z. W., & Guo, Y. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125447
FOXP1 Knockdown Reprograms Th9 CAR‐T Cells to Overcome Antigen Escape
Zhu, Y., Xie, X., Wu, X., Ouyang, S., Zhou, Y., Wen, K., Zhong, Y., Chen, Y., Wang, H., Gao, Y., et al. (2026) · Advanced Science · doi:10.1002/advs.77564
Self-citationFu, J., Pei, S., Du, J., Deng, X., Wang, X., Li, T., Huang, H., Ye, J., Xu, J., Wang, X., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.09.004
Self-citationTang, S., Xu, W., Li, Y., Liu, C., Liu, W., Liang, R., Liao, Q., Sun, H., Wang, Z., Shi, L., et al. (2026) · Molecular Medicine Reports · doi:10.3892/mmr.2026.14048
T-cell immunity in anti-tumor battle
Qin, Y., Yan, K., Li, D., Zhang, J., Guo, Z., Zhang, Y., & Lü, W. (2026) · Cellular and Molecular Immunology · doi:10.1038/s41423-026-01483-y
Mechanosensitive YAP–RUNX1 signaling drives TH1 cell dysfunction and tumor immunosuppression
许自兰, Deng, S., Zhao, H., Wang, D., Jin, Q., Xue, C., Liu, S., Liu, S., Zeng, L., Chen, Z., et al. (2026) · Nature Immunology · doi:10.1038/s41590-026-02708-y
Metadata
- Authors
- Lu, Y., Hong, S., Li, H., Park, J., Hong, B., Wang, L., Zheng, Y., Liu, Z., Xu, J., He, J., Yang, J., Qian, J., & Yi, Q.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Yi, Qing
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2012-10-15
- Volume
- 122
- Issue
- 11
- Pages
- 4160-4171
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3484462
- OpenAlex
- W2066906123
- Cited by
- 361
- References
- 50
- Citations by year
- 2026: 13 · 2025: 22 · 2024: 19 · 2023: 25 · 2022: 27 · 2021: 24 · 2020: 33 · 2019: 37 · 2018: 35 · 2017: 34 · 2016: 34 · 2015: 26 · 2014: 18 · 2013: 13 · 2012: 1
- FWCI
- 8.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Multiple Myeloma Research Foundation
- Commonwealth Foundation
- Leukemia and Lymphoma Society
- University of Texas MD Anderson Cancer Center
- National Cancer Institute (R01CA138402, R01CA138398, R01CA163881, P50CA142509, P30CA016672)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- Th9 cells, IL-9, antitumor immunity, pulmonary melanoma, CD8+ cytotoxic T lymphocytes, dendritic cell recruitment, tumor antigen delivery, draining lymph nodes, cancer immunotherapy, CD4+ T cells
- MeSH terms
- Animals, Dendritic Cells, T-Lymphocytes, Helper-Inducer, Immunity, Cellular, Immunotherapy, Lung Neoplasms, Melanoma, Interleukin-9, Antigen Presentation, Mice, Knockout, CD8-Positive T-Lymphocytes, Cell Line, Tumor, Mice, Receptors, CCR6, Chemokine CCL20
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.